The Effect of Different Neuromodulation Techniques in the Treatment of Multiple Sclerosis Patients With Neurogenic Bladder Dysfunction

CompletedNot a drug-phase studyMS (type not specified)NCT05312138

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Transcutaneous Posterior Tibial Nerve Stimulation

Compared with

  • Repetitive Transcranial Magnetic Stimulation

What it measured

Main measures

  • Urodynamics Test

    "10 days" the amount of change after 10 days from the baseline

    Bladder, bowel and sexual function
  • Extended Disability Status Scale (EDSS)

    "10 days" the amount of change after 10 days from the baseline

    Disability progressionBladder, bowel and sexual function
  • Overactive Bladder Questionnaire-V8 (OAB-V8)

    "10 days" the amount of change after 10 days from the baseline

    Bladder, bowel and sexual function
  • Incontinence Quality of Life -I-QOL

    "10 days" the amount of change after 10 days from the baseline

    Bladder, bowel and sexual functionQuality of life (reported by participants)
  • Voiding Diary

    "10 days" the amount of change after 10 days from the baseline

    Bladder, bowel and sexual function
  • Incontinence Severity Index (ISI)

    "10 days" the amount of change after 10 days from the baseline

    Bladder, bowel and sexual function

Who could take part

MS (type not specified) · 18 to 65

Show the full criteria

Inclusion criteria

* 18-65 years old * Woman * Volunteer to participate in the study * Neurogenic overactive bladder due to MS * EDSS \<7.0 * Not benefiting from pharmacological treatment

Exclusion criteria

* With urinary tract infection * Diagnosed with diabetes mellitus * Using diuretic medication * Using clean intermittent catheterization * Having a history of different urological diseases * Those who have conditions that would be contraindicated for electrical stimulation (pacemaker, brain pacemaker, prosthesis)

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Urinary symptoms are frequently seen in patients with Multiple Sclerosis (MS). Early evaluation of the patients in terms of the urinary system, planning the appropriate treatment and following up at regular intervals are extremely important in terms of preventing urinary system complications. Neuromodulation applications are used reliably in the urological treatment of MS patients. The aim of this study was to compare the efficacy of different neuromodulation techniques, transcutaneous posterior tibial nerve stimulation and repetitive transcranial magnetic stimulation, in patients with MS reporting lower urinary tract symptoms.

Papers

Loading reviews and guidelines…

History

    1. Started

      Jun 2021

    2. Main results due

      Oct 2022

    3. Finished

      Dec 2022

    Assembled by software from public sources.